Disease | graves disease |
Phenotype | |hyperthyroidism |
Sentences | 61 |
PubMedID- 23762777 | More frequent than graves' disease as the cause of hyperthyroidism is the syndrome of gestational hyperthyroidism or gestational transient thyrotoxicosis, diagnosed in about 3–5% of pregnancies and includes women with hyperemesis gravidarum, multiple pregnancies, and hydatidiform mole [13]. |
PubMedID- 25714667 | Objective: the first dose of radioiodine (i) does not always cure hyperthyroidism in patients with graves' disease (gd). |
PubMedID- 24145612 | (64) evaluated the change in visfatin, c-reactive protein (crp) concentration, and insulin sensitivity in 19 patients with hyperthyroidism due to graves' disease and 19 age- and sex-matched controls. |
PubMedID- 26512271 | The underlying case was hyperthyroidism due to graves' disease. |
PubMedID- 23127548 | Introduction: the association hyperthyroidism-exophtalmia is pathognomonic of the graves disease. |
PubMedID- 22937417 | The present paper illustrated a recurrence of catatonic episodes associated with hyperthyroidism due to graves' disease, which responded to antithyroid therapy in the first episode but required ect when relapsed. |
PubMedID- 19906789 | Conclusions: rai combined with lithium is safe and more effective than rai alone in the cure of hyperthyroidism due to graves' disease. |
PubMedID- 21845321 | In some cases, it is presented as hyperthyroidism because of graves' disease. |
PubMedID- 24262983 | hyperthyroidism due to graves' disease is autoimmune in origin. |
PubMedID- 21738852 | The 3 cases of hyperthyroidism were due to graves' disease. |
PubMedID- 23661330 | Incidence of hyperthyroidism due to graves' disease (gd) in poland is estimated at about one case per 25,000 persons per year [1]. |
PubMedID- 23312275 | [treatment of hyperthyroidism due to graves' disease: what is the recommended antithyroid drug during pregnancy. |
PubMedID- 22685686 | Around 10% of the positive trs-ab patients remained with elevated circulating trs-ab levels at the end of the follow-up and these patients continued to have hyperthyroidism due to graves' disease. |
PubMedID- 25433782 | Differentiation between hyperthyroidism due to graves' disease and the usually self-limited gestational transient thyrotoxicosis is critical. |
PubMedID- 26366174 | The study involved 33 patients (7 men), age 48 ± 15 years, bmi 24.2 ± 3.5 kg/m2, with hyperthyroidism due to graves' disease (n = 15) or toxic multinodular goitre hospitalized in the department of endocrinology and metabolic diseases. |
PubMedID- 26300942 | The hyperthyroidism and goiter of graves disease are caused by stimulation of the thyroid by tshr-ab9). |
PubMedID- 22632368 | Optimal therapeutic choices for the hyperthyroidism associated with graves' disease (gd) in the presence of go remain controversial. |
PubMedID- 21860806 | Patients (i) with known thyroid cancer, (ii) without an available serum tsh concentration within 1 year before surgery, (iii) with a final histological diagnosis other than dtc (e.g., medullary thyroid cancer or anaplastic thyroid cancer), and (iv) hyperthyroidism due to the graves disease were not included. |
PubMedID- 24853882 | Stress triggers the onset and the recurrences of hyperthyroidism in patients with graves' disease. |
PubMedID- 23864857 | Eleven patients suffered from hyperthyroidism in the course of graves' disease in the past (1–31 years prior to the establishment of diagnosis of adrenocortical insufficiency), and an adrenocortical insufficiency was diagnosed during the treatment of hyperthyroidism in 4 patients. |
PubMedID- 24825088 | We report here a case of a 6-year-old girl who was admitted for jaundice and pruritus as a result of the development of hyperthyroidism due to graves' disease. |
PubMedID- 22521493 | Thyroid function test confirmed hyperthyroidism due to graves' disease. |
PubMedID- 24592349 | Radioactive iodine treatment (rai) is an accepted treatment for hyperthyroidism associated with graves' disease and metastatic papillary thyroid carcinoma (ptc) following surgical resection in adults and children [5, 6]. |
PubMedID- 24367378 | In the present study, we determined serum levels of the soluble forms of intercellular adhesion molecule-1 (sicam-1), vascular cell adhesion molecule-1 (svcam-1), e-selectin, vwf, interleukin-6 (il-6): il-12, il-18, and c-reactive protein (crp) in patients with subclinical and overt hyperthyroidism (oh) due to graves disease (gd) and toxic nodular goitre (tng), in order to evaluate the possible role of these factors as potential markers of ed resulting from thyroid dysfunction. |
PubMedID- 22425314 | hyperthyroidism due to graves-basedow disease in a woman refractory to thyroid hormones. |
PubMedID- 23490308 | Neonatal hyperthyroidism in the offspring of mothers with graves' disease treated with radioiodine. |
PubMedID- 22824515 | Conclusion: this is the first reported case of t cell lymphoblastic lymphoma and the third reported case of thymoma associated with sustained hyperthyroidism due to graves disease. |
PubMedID- 23185197 | Introduction: failures in apoptotic pathways can contribute to various autoimmune diseases, including autoimmune hyperthyroidism due to graves' disease (gd). |
PubMedID- 21318144 | The study enrolled 19 patients with hyperthyroidism due to graves' disease (14 women and 5 men) and 19 age- and sex-matched euthyroid controls (17 women and 2 men) as previous study mentioned [12]. |
PubMedID- 24020400 | Results: only euthyroid postmenopausal patients with a history of hyperthyroidism due to graves' disease showed lower whole body bmd than matched controls. |
PubMedID- 24695373 | Definitive treatment with radioactive iodine or thyroidectomy should be given to patients with hyperthyroidism due to graves' disease, multinodular goiter, or toxic adenoma. |
PubMedID- 25927843 | Background: graves' disease, a well-known cause of hyperthyroidism, is an autoimmune disease with multi-system involvement. |
PubMedID- 25346920 | graves' disease, the main cause of hyperthyroidism in the pediatric age group, is very rare in children younger than 4 years old but can seriously interfere with growth and development if not recognized and treated. |
PubMedID- 20938101 | The prevalence of menstrual disturbances, including secondary amenorrhea, hypomenorrhea, oligomenorrhea, hypermenorrhea, polymenorrhea and irregular menstrual cycle were prospectively examined in 586 patients with hyperthyroidism due to graves' disease, 111 with hypothyroidism, 558 with euthyroid chronic thyroiditis, 202 with painless thyroiditis and 595 with thyroid tumor. |
PubMedID- 22002574 | In addition, there were 56 benign thyroid disease patients (22 males and 34 females; age range 15–62 years) that served as disease controls, including 36 patients with hyperthyroidism due to graves' disease (hyperthyroidism group) and 20 patients with hypothyroidism due to hashimoto's thyroiditis (hypothyroidism group). |
PubMedID- 26222916 | Background: to control hyperthyroidism due to graves' disease, antithyroid drugs should be administered. |
PubMedID- 26413185 | Based on laboratory and histopathological reports, a diagnosis of hyperthyroidism due to grave's disease with cutaneous myxedema was made and the patient was sent to medicine and ophthalmology departments for complete evaluation. |
PubMedID- 21398613 | Impairment of regulatory capacity of cd4+cd25+ regulatory t cells mediated by dendritic cell polarization and hyperthyroidism in graves' disease. |
PubMedID- 23757259 | Thus, elevated hyperthyroidism due to graves' disease served as a purging method. |
PubMedID- 26336606 | A clinical diagnosis of primary hyperthyroidism due to graves' disease was established, and thyrostatic treatment with thiamazole (mmi; 10 mg daily) was initiated. |
PubMedID- 21789282 | Some cases of patients with hyperthyroidism due to graves' disease presenting with coronary artery spasm have been reported [126–128]. |
PubMedID- 20467362 | The presence of thyroid eye disease (ted) may influence the treatment of hyperthyroidism in patients with graves' disease. |
PubMedID- 20871813 | We describe acute myopathy following i-131 treatment for hyperthyroidism due to graves disease (gd) in an adolescent. |
PubMedID- 24852589 | Thyroid function testing was diagnostic of primary hyperthyroidism due to graves disease in both cases. |
PubMedID- 26060496 | He was diagnosed as having hyperthyroidism due to graves' disease and started treatment with mmi (10 mg twice daily) and propranolol (10 mg thrice daily). |
PubMedID- 23705898 | The rare situation of hyperthyroidism with graves' disease in twins has been reported in a very few case reports in literature. |
PubMedID- 23043191 | Context: more than two decades have passed since members from the american thyroid association (ata), european thyroid association, and japan thyroid association were surveyed on management practices for patients with hyperthyroidism due to graves' disease (gd). |
PubMedID- 23440099 | Objectives: to evaluate the occurrence of cardiovascular disease and malignant tumors and the mortality rate in patients who received radioiodine treatment for hyperthyroidism due to grave's disease with at least ten years of follow-up. |
PubMedID- 20929407 | Background: subclinical hyperthyroidism is usually associated with graves' disease or toxic nodular goiter. |
PubMedID- 26108596 | Methods: this is a retrospective observational study using the data of 71 omani patients with a diagnosis of hyperthyroidism due to grave's disease, toxic multinodular goiter, and solitary toxic adenoma. |
Page: 1 2